The Readout Loud

Episodes

• Episode 163: Marilynn Marchione on covering the CRISPR babies scandal

  Jun 3, 2021

  Not summarized yet

• Episode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

  May 27, 2021

  Not summarized yet

• Episode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity

  May 20, 2021

  Not summarized yet

• Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit

  May 13, 2021

  Not summarized yet

• Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging

  May 6, 2021

  Not summarized yet

• Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt

  Apr 29, 2021

  Not summarized yet

• Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside

  Apr 22, 2021

  Not summarized yet

• Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19

  Apr 15, 2021

  Not summarized yet

• Episode 155: AstraZeneca's vaccine woes, compassionate use, & giving out Covid vaccines

  Apr 8, 2021

  Not summarized yet

• Episode 154: Eleanor Fox on Illumina’s FTC headache, plus Talkspace’s experiment

  Apr 1, 2021

  Not summarized yet

• Episode 153: AstraZeneca and the very good, then quite bad, then deeply confusing week

  Mar 25, 2021

  Not summarized yet

• Episode 152: Alison Buttenheim on Europe's vaccine scare, Lilly's Alzheimer's data, & a PR plea

  Mar 18, 2021

  Not summarized yet

• Episode 151: Natasha Loder on Covid vaccines, the demise of Watson Health, and a 'synbio' explainer

  Mar 11, 2021

  Not summarized yet

• Episode 150: Ashish Jha on Covid-19 optimism, plus pharma cooperation, & the next pandemic phase

  Mar 4, 2021

  Not summarized yet

• Episode 149: Nancy Goodman on Covid vaccines for kids, & Greg Zuckerman on Novavax's remarkable rise

  Feb 25, 2021

  Not summarized yet

• Episode 148: Akshay Sharma on gene therapy's setback, biotech's brashest VCs, & the FDA's future

  Feb 18, 2021

  Not summarized yet

• Episode 147: David Fajgenbaum on Covid-19 drugs, the state of the pandemic, & meme biotech stocks

  Feb 11, 2021

  Not summarized yet

• Episode 146: Paul Offit on vaccine data, 23andMe is going public, & Merck's CEO is retiring

  Feb 4, 2021

  Not summarized yet

• Episode 145: Kevin Davies on the CRISPR boom, & Megan Ranney on scientific misinformation

  Jan 28, 2021

  Not summarized yet

• Episode 144: Remembering STAT's Sharon Begley

  Jan 22, 2021

  Not summarized yet